Part 5 of 5
/ Review of the year 2024: In the first 4 parts

of my investment story, I looked at the years 2013 to 2023.

A mixture of highs and lows. While there was a lot of learning at the beginning, the last few years are finally bearing fruit!

Monthly view:

2024 was another very positive year, although December again resulted in a slight loss in the portfolio.

In total, December was -0,8%. This corresponds to price losses of -3.200€.

The MSCI World (benchmark) was -0.9% and the S&P500 -2.5%.

In the following, however, I would like to look primarily at the whole of 2024 and not

just December.

Year as a whole:

Winners & losers:

The winner par excellence is hardly surprising NVIDIA $NVDA (+0,6%) with

almost €20,000 in share price gains! And this despite the fact that I took my entire stake of ~€4,000 off the table in March.

In 2nd place follows Bitcoin
$BTC (-1,89%) with approx. 6,000€ price gains. 3rd-5th place

are shared by TSMC $TSM (+1,24%)
Alphabet $GOOG (+0,43%) and Meta
$META (-0,27%) with gains of ~€5,000 each.

On the loser side it looks very relaxed all in all.

Sartorius $SRT (+1,33%)
Nike $NKE (+0,76%)

and Bechtle $BC8 (-0,66%) have each caused share price losses of ~€1,000. They are followed by LVMH $MC (+1,17%) with share price losses of €500 and Amgen $AMGN (+0,42%) with €200.

All in all, share price losses that are not really worth mentioning.

The performance-neutral movements in 2024 were just under €20,000. This is a significant decline compared to the almost €30,000 from previous years. This was due to some private issues and the upcoming house construction.

My performance for the year as a whole was +28,8% and therefore outperformed my benchmark, the MSCI World, by 25.8%.

In total, my portfolio currently stands at ~347.000€. This

corresponds to an absolute growth of ~95,000€ in the current

year 2023. ~71.000€ of which comes from price gains, ~3.800€ from

dividends / interest and ~20.000€ from additional investments.

Dividend:

• The dividends in December were 17% above the previous year at ~€370
• Amgen is in the lead with over 50€ (gross) dividend every 3 months
• For the year as a whole, my dividends amounted to ~2.900€ and thus almost 25% over 2023

Buys & sells:

- I bought in December for a significantly reduced ~500€

- As always, my savings plans were executed:

- Blue chips: Lockheed Martin $LMT (+1,29%) Republic Services $RSG (+0,06%) Thermo Fisher $TMO (-0,17%) ASML $ASML (-0,33%) Northrop Grumman $NOC (+0,09%) Itochu $8001 (-2,87%) Constellation Software $CSU (+0,34%) Hermes $RMS Salesforce $CRM (+0,03%) MasterCard $MA (+0,68%) Deere $DE (+0,06%)

- Growth: -

- ETFs: MSCI World $XDWD (-0,11%) and the WisdomTree Global Quality Dividend Growth $GGRP (+0,23%)

- Crypto: Bitcoin $BTC (-1,89%) and Ethereum $ETH (-0,72%)

- There were no further sales in December

Target 2024 & outlook 2025:

My goal for 2024 was to reach €300,000 in the portfolio. Due to the

extremely positive market performance in the current year, my portfolio stands at ~€ 350,000 at the end of the year. I was therefore able to significantly exceed my target.

What will happen in 2025? The logical target, of course, would be 400.000€ to be achieved. However, due to the upcoming house construction, part of the assets will be invested in the house construction. If I include the property in my statement of assets, the target of €400,000 would of course not change.

However, as I am more likely to be tracking my liquid assets here, I will probably

probably refrain from doing so.

Therefore, my year-end target for 2025 will probably be closer to the final balance for 2024. So around €350,000 at the end of 2025.

How are things looking for you? Have you already thought about your plans for 2025?

Finally, I wanted to say thank you again for all the positive reactions to my investment story!

https://linktr.ee/mister.ultra

#dividends
#dividende
#rückblick
#depotupdate
#aktie
#stocks
#etfs
#crypto
#personalstrategy

Part 4 of 5: During part 1 and 2 were my apprenticeship years on the stock exchange, Part Part 3 highlighted the very positive years 2019-2021. In part 4 it is now the turn of 2022 and 2023. Part 5 will then conclude my investor story (so far) and shed light on 2024.

2021 was an extremely positive year with a performance of over 30% and assets of almost €200,000 at the end of the year.

However, from mid-2021 onwards, you could already sense that something was slowly changing. Inflation has picked up significantly worldwide. The main reasons for this are the global supply chain problems and the massive money printing by the central banks. Both are direct consequences of the coronavirus pandemic.

The year 2022 - inflation & interest rate turnaround

The year 2022 began with a significant setback in January. My portfolio was down 8% in January. There was a lot of unrest on the markets, inflation was still far too high and it was not clear how much the Fed would raise interest rates. In addition, there were fears that Russia could invade Ukraine - four weeks later this was unfortunately a sad certainty.

Uncertainty - something that the markets do not like at all. In addition to inflation, the war in Ukraine suddenly created another risk: what impact will the war and the sanctions have on global supply chains, which are still under heavy strain? Will this

inflation even further and thus put even more pressure on the central banks?

The stock market was therefore under fire from all sides:

• Supply chains are weighing on companies
• Higher interest rates lead to higher interest costs for companies
• Higher inflation increases salary and purchasing costs, while sales fall as consumers (have to) save more
• Suddenly, call money accounts and bonds become more interesting again and there are alternatives to shares (TINA = there is no alternative was therefore off the table)

Above all tech and growth stocks suffered from further problems:

Many growth companies were not yet profitable, but could borrow money cheaply from anywhere - profits were irrelevant as long as sales were growing. By 2022, this had changed and unprofitable companies were even shunned. Another reason is the valuation of future profits. If inflation is 0%, profits will be worth the same in five years' time as they are today. If inflation is 5%, I have to discount the profit in five years at 5% and suddenly the profit in five years is worth much less in real terms.

If I invest in my portfolio 2022 there are only a few winners:

At the top were defense companies like Lockheed Martin $LMT (+1,29%)

and Northrop Grumman $NOC (+0,09%) . This was followed by safe-haven stocks like Pepsi $PEP (+0,66%)
Unilever $ULVR (+0,87%) or Johnson & Johnson $JNJ (+0,33%) Also Encavis $ECV (-0,03%) was also in demand as an electricity producer due to the lack of gas from Russia.

At the bottom was everything to do with tech had to do with technology. The hardest hit were the unprofitable tech companies like Teladoc Health $TDOC (-0,02%) or Match Group $MTCH (-0,57%) caught - both with 70% losses each.

But also Meta $META (-0,27%)
had price losses of 60%! The reason was not only the general situation but also the lack of faith in the Metaverseso that Meta also had an internal problem. In 2022, Meta was already counted as the next GE or IBM.

But also NVIDIA
$NVDA (+0,6%) also lost -45% got a good beating. Microsoft $MSFT (+0,11%)
Apple $AAPL (+0,17%) and Alphabet $GOOG (+0,43%) saw their share prices fall by -20 to -35% were also unable to escape.

What has me in the year 2022 keep going in 2022?

On the one hand, the thought that I can now buy many top companies much more cheaply, but on the other hand also the dividends. My dividends increased by almost 50% in 2022 compared to 2021 and at the end of the year I had dividends of over €1,800.

That's an average of €150 per month and that's with dividend growth companies and not high-dividend ETFs or similar.

Nevertheless, the statement at the end of the year didn't exactly look rosy. Having started with €193,000, at the end of 2022 the portfolio only stood at 178.000€ even though I had over 30.000€ invested. Price losses of ~€45,000 hit like a bomb.

After another slap in the face in December 2022 with -5%, everything should suddenly be forgotten at the turn of the year.

The year 2023 - Inflation, high interest rates? Never mind, we have AI!

On November 30, 2022, the world ChatGPT and since then we have been in an AI rallythat still has no end in sight at the end of 2024. The performance of the portfolio has turned 180 degrees. Everything that was at the top in 2022, such as pharma or consumer staples (Procter & Gamble, Pepsi,...) was suddenly at the bottom.

Suddenly at the top were NVIDIA and Meta with almost +200%.

With Crowdstrike, Salesforce and Palo Alto Networks there were

another three doublers in the portfolio. One Apple was with +40% already

rather a low performer.

The stock market got used to the normalized interest rate environment, supply chains were relatively intact again and inflation began to fall. All in all, a positive environment for the stock market, which was driven back up by a megatrend (artificial intelligence).

On the home stretch in December 2023, my portfolio was just about able to make up for all the price losses from 2022. In addition to price gains of ~€45,000, I also invested another ~€30,000, so that my portfolio increased by ~€75,000 in absolute terms.

My portfolio ended the year at ~178.000€ and at just over 250.000€ ended the year.

The dividends have also continued to rise nicely - from 1.900€

to almost 2.400€ upwards.

Asset development & return:

Year Deposit value Return

2022 179.000€ -21%

2023 252.000€ +24%

Vermögensentwicklung 2022-2023:

Outlook:

Vermögensentwicklung 2013-2023:

Outlook:

In the next part, I will look ahead to the year 2024 and thus also my portfolio update / annual overview cover.

The year 2024 continued to be characterized by AI, but also by falling interest rates and some political upheavals (Trump, traffic lights out,...).

The portfolio continued to perform extremely well in 2024, although the savings rate was lower than in previous years due to a number of private issues. Nevertheless, for the first time the 300.000€ in the portfolio was to be significantly exceeded.

Part 1: https://app.getquin.com/de/activity/PElWrODsmV

Part 2: https://app.getquin.com/de/activity/LUkWiLtZKX

Part 3: https://app.getquin.com/de/activity/mQAzDvfidK

#strategy

#personalstrategy

#etfs

#dividends

$NOC (+0,09%) Northrop Grummann

$LMT (+1,29%) Lockheed Martin

*Both at the all time high today*

With sales of over 39 billion dollars, Northrop Grummann $NOC (+0,09%) is a major global aerospace and defense technology company responsible for several critical components of America's defense and NASA's space program. The company develops complex platforms that last for decades, regardless of current events. The S&P 500-listed company is the primary supplier for the modernization of the United States' nuclear weapons systems.

The old B-2 Spirit stealth bomber model is to be replaced by the new B-21 Raider variant, and a new generation of intercontinental missiles is being developed as part of the Sentinel program. Both programs extend over several decades and promise stable revenues. Test flights with the B-21 are currently taking place and the handover is planned for the 2020s. The first operational Sentinel system should be fully operational by around 2029.

After several years of heavy investment in product development and capacity expansion, the end is gradually approaching. In the first half of the year, sales grew by 8% year-on-year to USD 20.4 billion, with a stable EBIT margin of 10.8%. The largest increases were recorded in the Aeronautics and Defense Systems segments. With an order backlog of USD 83 billion, CEO Kathy Warden expects sales of around USD 41 billion and earnings per share of between USD 24.90 and 25.30 for the 2024 financial year. If this is achieved, the 2024 P/E ratio of the share (USD 513.73; US6668071029) is currently

20The most recent example is the USD 1.3 billion contract that the Americans were able to land together with their joint venture partner Raytheon on August 30. This involves the production of around 50,000 Javelin missiles and more than 12,000 reusable command and control units.

The Javelin program is part of the "Missiles and Fire Control" segment, which generates around 17% of Group sales and recorded the highest growth rate in H1 2024 (+18.5% year-on-year). Overall, revenue increased by 11% to USD 35.3 billion in the period under review.

In terms of size, the "Aeronautics" segment is the most significant with a 40% share of sales. This includes the F-35 fighter jet, which is also very popular in Germany. According to media reports, the German government is currently discussing the procurement of a further tranche of eight F-35 jets for the German armed forces.

Lockheed $LMT (+1,29%) is continuously working on its flagship product; the first model with the latest technology was recently delivered. CEO Jim Taiclet expects a total of 75 - 110 F-35 jets to be delivered in FY 2024. The fruits of many years of development work should now be reaped in the coming years, which should gradually have a positive impact on profitability.

The forecast for the financial year envisages an EBIT margin of 10.4% (2023: 12.6%), with sales of 70.5 to 71.5 billion (2023: 67.6 billion dollars). The order backlog as at June 30 amounted to almost USD 160 bn, more than double the expected revenue.

Following the strong share price performance, the valuation has risen to 22 times the expected earnings per share for 2024.

I was introduced here several times about 12 months ago and decided to buy.

My thanks go to:

@7Trader
@Asgard19
@Der_Dividenden_Monteur

@Simpson and @Michael-official

who drew my attention to it.

Depot review September 2024 - The first green September in my depot since 2019 📈

September is generally regarded as the worst month on the stock market, with a negative monthly performance more than 50% of the time. This is also consistent with my experience since 2013. In 11 years, it has been negative 6 times and positive 5 times. From 2020 to 2023, the last 4 years were all negative. However, September 2024 is now the first positive September since 2019, which means it is exactly 50/50 for me - 6 positive and 6 negative Septembers since 2013.

The Fed's interest rate turnaround and the stimulus in China have certainly contributed to the positive trend

Monthly view:

In total, September was +1,2%. This corresponds to price gains of ~3.600€.

The MSCI World (benchmark) was +1.0% and the S&P500 +1.3%

Winners & losers:

A look at the winners and losers is particularly exciting this month.

On the winning side at the very top are my China ETF with € +1,300 and is thus back in the green for the first time in a long time. The following winners are also a colorful mix with Meta, Bitcoin, Home Depot and Sea. Really a very broad mix with no clear tendency towards regions, sectors or the like

On the loser side in my portfolio in September were mainly pharmaceutical stocks. Novo Nordisk, Amgen and Johnson & Johnson. Even worse, with price losses of ~€700 each, were only Palo Alto Networks and ASML.

The performance-neutral movements in September were just under €4,500. The premium refund from my private health insurance also played a large part in this. In September, I received over €2,000 back for the year 2023, which was of course invested directly to compensate for any higher pension contributions.

Current year:

My performance in the current year is +20,4% and thus above my benchmark, the MSCI World with 17.2%.

In total, my portfolio currently stands at ~321.000€. This corresponds to an absolute growth of ~€69,000 in the current year 2023. ~49.000€ of this comes from price increases, ~2.800€ from dividends / interest and ~17.000€ from additional investments.

Dividend:

• Dividends in September were 23% above the previous year at ~€360
• Amgen is in the lead with a (gross) dividend of €50 every 3 months. But Johnson & Johnson with €45 is also a delight
• In the current year, the dividends after 9 months are +25% over the first 9 months of 2023 at ~2.210€

Buys & sells:

• I bought in September for approx. 3,500€. 2,100 of this came from the premium refund from my private health insurance and went into the WisdomTree Global Quality Dividend Growth
• As always, my savings plans were executed:
• Blue ChipsLockheed Martin $LMT (+1,29%) Republic Services $RSG (+0,06%) Thermo Fisher $TMO (-0,17%) ASML $ASML (-0,33%) MasterCard $MA (+0,68%) Deere $DE (+0,06%) Northrop Grumman $NOC (+0,09%) Itochu $8001 (-2,87%) Salesforce $CRM (+0,03%) Hermes $RMS (-0,61%) Constellation Software $CSU (+0,34%)
• 
  Growth: -
• ETFsMSCI World $XDWD (-0,11%) Nikkei 225 $XDJP (-0,67%) and the WisdomTree Global Quality Dividend Growth $GGRP (+0,23%)
• 
  Crypto: Bitcoin $BTC (-1,89%) and Ethereum $ETH (-0,72%)
• 
  Sales there were none in September

Target 2024:

My goal for this year is to reach €300,000 in my portfolio. Due to the extremely positive market development in the current year, my portfolio currently stands at ~€321,000.

At the beginning of September, my portfolio was still quite a bit lower at €304,000 due to the weak start to the month. At this point, it was therefore quite a way off the previous high of €320,000 in June.

I have now reached a new high of €321,000 and am optimistic that I can still beat my year-end target of €300,000.

#dividends

#dividende

#rückblick

#depotupdate

#aktie

#stocks

#etfs

#crypto

#personalstrategy

Depot update:

I have again exchanged a few of my 45 long-term individual positions for stocks that I simply feel more comfortable with for the next few years.

Once again, a brief summary of my strategy:

1) I want to bring the two large ETF positions to 25% weighting each, as the core of the portfolio.

2) I would like to hold and save the 45 individual positions for the long term, as I consider them to be good buy & hold investments that have the potential to beat the market in the long term.

3) I would like to hold cryptos at a weighting of around 5%. If the weighting exceeds 10%, I halve it again and invest the money freed up in equities.

Considerations/plans:

- Additional purchases are planned for positions that are not yet as large for me, for example. $NOC (+0,09%) I would like each position to be at least €600

• Also bid $V (+0,13%)
  $CNR (-0,02%) and $WALMEX* (+2,28%) are currently offering me good opportunities for additional purchases
• I am currently considering "only" weighting the two ETFs with 20% each and also adding the $CSNDX (+0,02%) with a 10% weighting... But I don't think I will do that, the heavyweights from the Nasdaq 100 are already well weighted in my portfolio anyway

What do you think about the portfolio, what would you change?

PS: I'm not actively looking to collect a lot of dividends and I'm aware of the high number of individual stocks, so I can live with that.

Armaments shares from 🇺🇸 in comparison, the last 20 years, you can see only after 10 years have the 🚀 ignited.

I only have a large position in Lockheed and a small one in RTX.

But I invest in all 5 via a savings plan 😊👍

Do you have one or two armor stocks in your portfolio?

$LMT (+1,29%)
$RTX (+0,72%)
$GD (+0,35%)
$NOC (+0,09%)
$LHX (+0,06%)

Depot review March 2024 - And on, and on, and on,...

March picks up where February left off. And before that, January, December, November,...

In total, March was +2,9%! This was less than in January and February and was mainly driven by the first half of March. In total, this corresponded to price gains of ~8.000€.

Winners & losers:

On the winners' side is getting really boring. In 1st place, of course: NVIDIA
$NVDA (+0,6%) with share price gains of ~€2,100. 2nd place goes to Alphabet
$GOOG (+0,43%) with €1,000. But also Bitcoin $BTC (-1,89%) also showed a strong performance with price gains of €800. The top 5 is then rounded off by two securities that I would rarely expect to see in the top 5: The MSCI World ETF $XDWD (-0,11%) and the German Bank $DBK (+0,6%)

On the losers' side there is a lot of tech. With Palo Alto Networks $PANW (-0,8%) and MercadoLibre $MELI (+1,26%)

two high growth tech stocks that were already at the bottom in February.
In addition Apple $AAPL (+0,17%)
Nike $NKE (+0,76%)

and Starbucks $SBUX (-0,07%) were weaker.

The performance-neutral movements in March amounted to € 1,300. As in January and February, a larger proportion is currently being spent on private expenses. Nevertheless, I was able to invest significantly more net in March than in January and February. I bought just over €2,000 in March. However, the net figure for the pure securities portfolio is a minus, as I sold my Encavis
$ECV (-0,03%) shares after the takeover offer from KKR. As a result, ~€2,600 flowed out of my securities account, which is now in the clearing account for 4%.

My performance for the current year is +14,7% and thus well above my benchmark, the MSCI World with 11.2%.

In total, my portfolio currently stands at ~291.000€. This corresponds to an absolute growth of ~€39,000 in the current year 2023. ~36.000€ of this comes from price gains, ~720€ from dividends / interest and ~2.000€ from additional investments.

Dividend:

• Dividends in March were +30% above the previous year at ~€350
• In the current year, the dividends after 3 months are also +30% over the first three months of 2023 at ~630€.
• In March, there was also a dividend for the first time from Meta $META (-0,27%)
  

Buys & Sells:

• I bought in March for approx. 2.000€
• Of which 500€ each in Hermes $RMS (-0,61%) and Constellation Software $CSU (+0,34%) as a first purchase
• In addition, the first few euros saveback from the Trade Republic card were also invested
• As always, my savings plans were executed:
• Blue ChipsNorthrop Grumman $NOC (+0,09%) MasterCard $MA (+0,68%) Salesforce $CRM (+0,03%) Deere $DE (+0,06%) Lockheed Martin $LMT (+1,29%) ASML $ASML (-0,33%) Thermo Fisher $TMO (-0,17%) Itochu $8001 (-2,87%) Republic Services $RSG (+0,06%) Hermes $RMS (-0,61%) Constellation Software $CSU (+0,34%)
  
• Growth: -
• ETFsMSCI World $XDWD Nikkei 225 $XDJP and the WisdomTree Global Quality Dividend Growth $GGRP
• CryptoBitcoin $BTC and Ethereum $ETH
• Sales there was the (involuntary) sale of Encavis in March $ECV (-0,03%)
  

Even though I was only able to add €2,000 net to my portfolio in the first quarter, the snowball had a very clear effect. Nevertheless, I will of course be investing more again in the medium term.

Target 2024:

My goal for this year is to reach 300.000€ in the portfolio. Now that my portfolio is already at €291,000, I have almost reached my target as of March.

However, I am still of the opinion that the markets will soon enter a sideways trend. In my opinion, this was already slightly indicated in the second half of March.

#dividends

#dividende

#rückblick

#depotupdate

#aktie

#stocks

#etfs

#crypto

#personalstrategy

$NOC (+0,09%)

Northrop Grumman today About us

Northrop Grumman is a leading global aerospace and defense company.

and defense technology company. Our pioneering

Solutions equip our customers with the capabilities

They must connect and protect the world, and

expand the frontiers of human exploration

the universe. Driven by a common goal to solve

The most difficult problems our customers, our employees

every day.

Figures:

84.2 billion US dollar backlog 2023

39.3 billion US dollars sales 2023

$2.1B 2023 free cash flow(1)

2.6 billion US dollars dividends 2023 and share buybacks

What we do

We build some of the most beautiful in the world

advanced aircraft. From the innovative

stealth bomber B-2 Spirit to the

groundbreaking X-47B, in addition to

powerful airborne sensors and systems.

Northrop Grumman for decades

protected the U.S. Armed Forces and our allies by

designing, developing and delivering

weapons of increasing complexity and

capabilities for expanded missions and

domains.

Sources:

https://investor.northropgrumman.com/

www.onvista.de

Thanks to:

@Asgard19

@ausgeklammert